研究目的
To develop MnO2 nanotubes-based, switchable photoacoustic imaging (PAI) to detect GSH for cancer diagnosis, addressing the limitations of current techniques such as fluorescence imaging, PET, and MRI.
研究成果
MnO2 nanotubes are a promising switchable and biodegradable PA probe for dynamic imaging of GSH for cancer diagnosis, successfully distinguishing melanoma from healthy controls. Future work includes optimizing the physiochemical properties of MnO2 nanotubes and developing a more compact PACT setup for clinical applications.
研究不足
The study focuses on melanoma as the disease model, and the applicability to other cancer types needs further investigation. The PACT system's size and the need for further development to mitigate the system size for clinical translation are also limitations.
1:Experimental Design and Method Selection:
Custom-built, linear-transducer-array-based photoacoustic computed tomography (PACT) systems were used for phantom and in vivo animal imaging.
2:Sample Selection and Data Sources:
MnO2 nanotubes were synthesized and characterized for their PA properties. B16F10 melanoma cells and BEAS-2B normal cells were used for in vitro studies, and CD-1 mice bearing B16F10 tumors were used for in vivo studies.
3:List of Experimental Equipment and Materials:
A 128-element linear array transducer (ATL/Philips L7-4), an Nd:YAG pumped optical parametric oscillator (OPO) laser, and a 128-channel ultrasound data acquisition (DAQ) system (Vantage, Verasonics) were used.
4:Experimental Procedures and Operational Workflow:
PA signals were measured before and after the interaction of MnO2 nanotubes with GSH in phantoms, cells, and tumors.
5:Data Analysis Methods:
PA signals were analyzed using the universal back-projection algorithm and normalized for comparison.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容